What kind of moron allows another organization to run tests on one of his company's products without any input, control, or right of access to the outcomes? Even for a fish bait salesman, that would be mind-numbingly stupid.
Of course, this is J Graham, so whether one believes such 'facts' is subject to one's own IQ. But before rushing to disregard the 'constant dribble' in this regard, you might at least ask - so what legitimate trials and/or testing did he organize to make up for these obvious deficiencies. Or is RCE somehow exempted from following the established protocols for new drug approval processing?
- Forums
- ASX - By Stock
- RCE
- Ann: Positive Ph I/II DFI Efficacy Data to Support Site Expansion
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Ann: Positive Ph I/II DFI Efficacy Data to Support Site Expansion, page-28
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 31.0¢ | $17.20K | 54.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5861 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 38346 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6135 | 0.310 |
1 | 5000 | 0.305 |
4 | 26603 | 0.300 |
3 | 39803 | 0.295 |
1 | 9274 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 18753 | 3 |
0.325 | 4066 | 1 |
0.330 | 144764 | 2 |
0.350 | 56319 | 5 |
0.375 | 8002 | 1 |
Last trade - 11.00am 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online